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Abstract
Background: Korean red ginseng (KRG) is a ginseng that has been cultivated and aged for 4-6 years or more, and
goes through an extensive cleaning, steaming and drying process. KRG contains more than 30 kinds of saponin
components and has been reported as having various biological properties, such as anti-fatigue action, immune
restoration, and neurovegetative effect. The purpose of this study was to assess the effects of a KRG-containing
drug (KRGCD) on gastric ulcer models in mice.
Methods: Stomach ulcers were induced by oral ingestion of hydrochloride (HCl)/ethanol or indomethacin.
Treatment with KRGCD (30, 100, and 300 mg/kg, p.o.) occurred 1 hr before the ulcer induction. Effect of KRGCD on
anti-oxidant activity and gastric mucosal blood flow with a laser Doppler flowmeter in mice stomach tissue was
evaluated.
Results: KRGCD (100 and 300 mg/kg, p.o.) significantly decreased ethanol- and indomethacin-induced gastric ulcer
compared with the vehicle-treated (control) group. KRGCD (100 and 300 mg/kg) also decreased the level of
thiobarbituric acid reactive substance (TBARS) and increased gastric mucosal blood flow compared with the control
group.
Conclusions: These results suggest that the gastroprotective effects of KRGCD on mice ulcer models can be
attributed to its ameliorating effect on oxidative damage and improving effect of gastric mucosal blood flow.
Background
Korean ginseng (the root of Panax ginseng, C. A. Meyer)
has been known to be a valuable and important folk
medicine in East Asian countries, including Korea,
China, and Japan, for about 2000 years and is now one
of the most extensively used botanical products in the
world [1,2]. Korean red ginseng (KRG) is a ginseng that
has been cultivated and aged for 4-6 years or more, and
goes through an extensive cleaning, steaming, and dry-
ing process [3]. Among the several kinds of Panax gin-
seng products, KRG has the most potent multiple
pharmacological actions for treating various human dis-
eases, including cardiovascular diseases, rheumatoid
arthritis, and diabetes mellitus [4,5].
Gastric ulcer is an illness that affects a considerable
number of people worldwide. The etiological factors of
this disorder include stress, smoking, alcohol, nutritional
deficiencies, infections, and frequent and indiscriminate
use of nonsteroidal anti-inflammatory drugs (NSAIDs)
[6]. The pathogenesis of gastroduodenal ulcers is influ-
enced by various aggressive and defensive factors, and
gastric mucosal blood flow is an important factor regu-
lating the gastric function [7]. A study on the effects of
KRG on patients with gastric cancer and post-operative
immunity showed that patients treated with KRG had a
higher survival rate with complete cure of disease [8].
Previously, the anti-ulcer effects of KRG have been
reported in water immersion stress-, serotonin-, and
endotoxin-induced gastric ulcer models [9]. On the
other hand, the effect of KRG on alcohol- and NSAIDs-
induced ulcer models has not been studied.
Ethanol is known to produce erosion, ulcerative
lesions, and petechial bleeding in the mucosa of the
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stomach in humans [10-12]. Ethanol rapidly penetrates
the gastric mucosa, and causes membrane damage, exfo-
liation of cells, erosion, and ulcer formation. Ethanol-
induced gastric ulcer models are commonly used to
study both the pathogenesis of and therapy for human
ulcerative disease [13].
Indomethacin, an NSAID, is widely prescribed in clini-
cal practice because NSAIDs exhibit excellent efficacy in
the management of pain, fever, and inflammation
through suppression of the synthesis of prostaglandins
(PGs) from arachidonic acids resulting from their inhibi-
tion of cyclooxygenase (COX) [14]. However, the use of
NSAIDs is also associated with significant risks of
adverse gastrointestinal events, such as gastric mucosal
erosion, ulceration, bleeding, and perforation [15,16].
In this study, we investigated the effects of the KRG-
containing drug (KRGCD) on acute gastric injury caused
by administration of ethanol or indomethacin in mice.
Methods
Animals
Six-week-old male ddY mice weighing 28-30 g were
used in this study. The animals were obtained from
colonies of specific conventional ddY mice maintained
by Japan SLC (SLC, Shizuoka, Japan). All procedures
relating to animal care and treatment conformed to the
animal care guidelines of the Animal Experiment Com-
mittee of Gifu Pharmaceutical University. All efforts
were made to minimize suffering and the number of
animals used. The animals were housed at 24 ± 2°C
under a 12 hr light-dark cycle (lights on from 8:00 to
20:00) and had ad libitum access to food and water.
Chemicals and drugs
The following chemicals and drugs were used: Ethanol,
hydrogen chloride, urethane, paraformaldehyde, indo-
methacin, ferrous sulfate (FeSO4), carboxymethylcellu-
lose (CMC), and sodium chloride (WAKO Pure
Chemical Industries, Osaka, Japan); perchloric acid
(HClO4) and thiobarbituric acid (TBA) (Sigma, St.
Louis, MO, USA); hydrochloride (HCl) (Nakarai Tesque,
Ltd., Kyoto, Japan); and sodium dodecyl sulfate (SDS)
(Life Technologies Japan Ltd., Tokyo, Japan). Sozinsan
AT, gifted from Meiji Seika Kaisha, Ltd. (Tokyo, Japan),
was used as the KRGCD. The KRGCD (1300 mg) con-
tained 133.33 mg of KRG powdered extract, 200 mg of
powdered Atractylodes lancea rhizome, 200 mg of pow-
dered cinnamon bark, 400 mg of powdered oyster shell,
133.33 mg of magnesium hydroxide, 66.67 mg of Cory-
dalis tuber powdered extract, and the appropriate
amount of inactive ingredients. KRG was gifted from
Nippon Funmatsu Yakuhin Co., ltd. (Osaka, Japan). Sel-
belle (Eisai Co., Ltd., Tokyo Japan) was used as the
teprenone-containing drug (TCD). Storage (Takeda
Pharmaceutical Co., Ltd., Osaka, Japan) was used as the
Anchusan prescribed drug (APD).
Hydrogen chloride (HCl)/ethanol-induced gastric ulcer
Gastric hemorrhagic lesions were induced by intragastric
administration (0.1 ml/20 g) of an HCl/ethanol mixture,
containing 150 mM HCl in 98% ethanol [17-19]. The
KRGCD dissolved in CMC (0.5% carboxymethylcellulose
solution dissolved in distilled water) was administered at
oral doses of 30, 100, and 300 mg/kg, 1 hr before HCl/
ethanol application. The TCD (76 mg/kg, p.o.)- and
APD (96 mg/kg, p.o.)-treated groups were included as
reference controls. We determined the doses of these
control drugs in relation to 100 mg/kg of KRGCD,
based on their defined daily dose for human (KRGCD:
3900 mg, TCD: 3000 mg, and APD: 3750 mg). One hr
after ethanol administration, the animals were killed by
cervical dislocation, and the stomachs were removed,
inflated with 1 mL of 1% paraformaldehyde overnight to
fix the tissue walls, and opened along the greater curva-
ture. The ulcer lesions were stretched out, and software
(Angiogenesis Image Analyzer, Kurabo, Osaka, Japan)
was used to estimate their sizes.
Indomethacin-induced gastric ulcer
Gastric hemorrhagic lesions were induced by intragastric
administration (0.1 ml/10 g) of 20 mg/kg of indomethacin.
KRGCD dissolved in CMC (0.5% carboxymethylcellulose
solution dissolved in distilled water) was administered at
oral doses of 30, 100, and 300 mg/kg, 1 hr before indo-
methacin application. The TCD (76 mg/kg, p.o.)- and
APD (96 mg/kg, p.o.)-treated groups were included as the
reference controls. We determined the doses of these con-
trol drugs in relation to 100 mg/kg of KRGCD, based on
their defined daily dose for human (KRGCD: 3900 mg,
TCD: 3000 mg, and APD: 3750 mg). Twelve hr after indo-
methacin administration, the animals were killed by cervi-
cal dislocation, and the stomachs were removed, inflated
with 1 mL of 1% paraformaldehyde overnight to fix the tis-
sue walls, and opened along the greater curvature. The
hemorrhagic lesions were stretched out, and software
(Angiogenesis Image Analyzer, Kurabo) was used to esti-
mate their sizes.
Histological analysis
Gastric tissue samples were fixed in neutral buffered for-
malin for 24 hr. Stomach sections were dehydrated with
graded ethanol, passed through xylene, and embedded
in paraffin. The paraffin sections (5 μm thick) were
stained with hematoxylin/eosin (HE).
Lipid peroxidation
In the in vitro model of lipid peroxidation, the superna-
tant fraction of a stomach homogenate from male adult
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ddY mice was prepared. Stomach tissues were homoge-
nized in Hiscotron homogenizer in 5 vols of ice-cold
1.15% sodium chloride solution. Then, 945 μL of sto-
mach homogenate was added to 5 μL of test compound
and 50 μL of FeSO4, and incubated at 37°C for 1 hr.
The reaction was stopped by adding 200 μL of 35%
HClO4, and then centrifuged at 3,000 rpm for 10 min.
The supernatant 500 μL was heated with 500 μL of
TBA, 750 μL of phosphate buffer, and 100 μL of SDS
for 60 min at 100°C. After being cooled, the reactants
were supplemented with an equivalent amount of n-
butanol, shaken vigorously for 1 min, and centrifuged
for 10 min at 4,000 rpm. Absorbance was measured
spectrophotometrically at 532 nm. In the ethanol-
induced gastric ulcer model, mice were pretreated with
CMC (p.o.) or KRGCD (30, 100, 300 mg/kg, p.o.) 1 hr
before ethanol. At 1 hr after the application of ethanol,
the animals were killed, and a glandular segment from
each stomach was homogenized in 5 vols of ice-cold
1.15% sodium chloride solution, and the method
described above was followed.
Measurement of gastric mucosal blood flow
Gastric mucosal blood flow was measured using a laser
Doppler flowmeter, FLO-N1 (Omegawave, Inc., Tokyo,
Japan), as described in our previous reports [20]. The
mice used for this measurement were anesthetized with
urethane (1.2 g/kg, i.p.), and the abdomen was opened
on an operation mat. The mat was heated at 37°C dur-
ing the operation and blood flow measurement. Then, a
non-contact probe was placed gently 1.0 mm above and
perpendicular to the mucosal surface in the pylorus area
to monitor gastric mucosal blood flow. After the gastric
mucosal blood flow was stable, saline, KRGCD (100 and
300 mg/kg, i.g.), and KRG (30 and 100 mg/kg, i.g.),
which dissolved in saline, were administrated directly
into the stomach with a cannula, and gastric mucosal
blood flow was monitored for 1 hr.
Statistical analysis
Data are presented as the means ± standard error of the
mean (SEM). Statistical comparisons were made with
Student’s t-test or one-way analysis of variance
(ANOVA) followed by Dunnett’s test using Statview ver-
sion 5.0 (SAS Institute Inc., Cary, NC, USA), with p <
0.05 being considered to indicate a statistical
significance.
Results
Effect of KRGCD on HCl/ethanol-induced gastric damage
The ulcer-preventive effect of KRGCD was evaluated by
using ethanol (containing 150 mM of hydrochloride)-
induced ulcers. Ethanol induced intense gastric mucosal
damage in the form of hemorrhagic streaks in the
control group of mice that received vehicle alone (Figure
1a and 1e). Oral treatment of 100 and 300 mg/kg of
KRGCD significantly reduced the gastric mucosal
damage and quantitative reduction in a dose-dependent
manner compared with the control-treated group (Fig-
ure 1b, c, d, and 1e). Compared with the reference
drugs, which were used at a dose equivalent to 100 mg/
kg of KRGCD, KRGCD is equally efficacious in the
treatment of TCD (76 mg/kg, p.o.) (Figure 1g, h, and
1j). APD (96 mg/kg, p.o.) also showed a tendency to
protect against ethanol-induced gastric damage, but the
tendency was not significant (Figure 1i and 1j).
Effect of KRGCD on indomethacin-induced gastric
damage
The gastroprotective effect of KRGCD on indomethacin-
induced gastric damage was macroscopically determined
in mice. Macroscopic lesions with evident borderlines in
various forms and sizes were dispersed irregularly on all
stomach surfaces in the stomach tissue of the control
mice that received indomethacin (Figure 2a). The mice
that received oral treatment of 100 and 300 mg/kg of
KRGCD showed gastric mucosal protection and quanti-
tative reduction in a dose-dependent manner compared
with the control-treated group (Figure 2b, c, d, and 2e).
Compared with the reference drugs, which were used at
a dose equivalent to 100 mg/kg of KRGCD, KRGCD is
equally efficacious in the treatment of TCD (76 mg/kg,
p.o.) (Figure 2g, h, and 2j). APD (96 mg/kg, p.o.) also
showed a tendency to protect against indomethacin-
induced gastric damage, but the tendency was not sig-
nificant (Figure 2i and 2j).
Effect of KRGCD on histological evaluation in an HCl/
ethanol-induced ulcer model
Histopathological studies further confirmed that pre-
treatment with KRGCD prevented ethanol-induced his-
tological damage in the superficial layers of the gastric
mucosa with congestion by HE staining. Compared with
the sham operating group, ethanol administration
induced a disruption of the superficial region of the gas-
tric gland with epithelial cell loss and intense edema for-
mation (Figure 3a and 3b). Histological analysis showed
that KRGCD (300 mg/kg, p.o.) prevented this damage
(Figure 3d), but not 30 mg/kg administration (Figure
3c). KRGCD (100 mg/kg, p.o.)-treated group showed
similar staining pattern to 300 mg/kg-treated group
(data not shown).
Effect of KRGCD on histological evaluation in an
indomethacin-induced ulcer model
Histopathological studies further confirmed that pre-
treatment with KRGCD prevented indomethacin-
induced histological damage in the superficial layers of
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the gastric mucosa with congestion by HE staining.
Compared with the sham operating group, indometha-
cin administration induced a disruption of the superfi-
cial region of the gastric gland with epithelial cell loss
(Figure 4a and 4b). Histological analysis showed that
300 mg/kg of KRGCD (p.o.) prevented this damage
(Figure 4d), but not 30 mg/kg (Figure 4c). KRGCD
(100 mg/kg, p.o.)-treated group showed similar stain-
ing pattern to 300 mg/kg-treated group (data not
shown).
Effect of KRGCD on lipid peroxidation
Gastric ulcer is well-accepted oxidative stress-induced
stomach disease, and the mechanism of ulcer induction
is mediated by reactive oxygen species (ROS). In vitro
lipid peroxidation levels in the mice stomach homoge-
nate was measured as TBARS used as an index of lipid
peroxidation. The TBARS level increased after 1-hr
incubation with FeSO4 at 37°C. KRGCD significantly
inhibited the production of the TBARS level in a con-
centration-dependent manner (Figure 5a). The
Figure 1 Protective effect of KRGCD on gastric mucosal lesions induced by HCl/ethanol in mice. Stomachs from mice with vehicle (a) and
pretreated with KRGCD at doses of 30 mg/kg (b), 100 mg/kg (c), and 300 mg/kg (d) at 1 hr before HCl/ethanol administration. Quantitative
analysis of KRGCD on the ulcer area (mm2) induced by HCl/ethanol (e). n = 13 for each group. Each value represents the mean ± SEM. * p <
0.05, ** p < 0.01 vs. control mice, Dunnett’s multiple-range test. Stomachs from mice with vehicle (f) and pretreated with KRGCD (100 mg/kg)
(g), TCD (76 mg/kg) (h), and APD (96 mg/kg) (i) at 1 hr before HCl/ethanol administration. Quantitative analysis of KRGCD, TCD, or APD on ulcer
area (mm2) induced by HCl/ethanol (j). n = 8 for each group. Each value represents the mean ± SEM. * p < 0.05 vs. control mice, Student’s t-test.
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antioxidant trolox (100 μM; a water-soluble vitamin E
derivative) also inhibited the production of TBARS. On
the other hand, KRG did not decrease the production of
TBARS in the mice stomach homogenate (Figure 5b).
Next, we investigated the anti-oxidative effects of
KRGCD in the in vivo model of an ethanol-induced gas-
tric ulcer. Ethanol significantly enhanced the TBARS
level compared to the values seen in the sham treating
group; pretreatment of animals with KRGCD (100 and
300 mg/kg, p.o.) resulted in marked suppression of
ethanol-induced TBARS (Figure 5c), indicating that this
agent suppressed lipid peroxidation.
Effect of KRGCD and KRG on gastric mucosal blood flow
Gastric mucosal blood flow plays an important role in
gastric ulcer pathogenesis and healing. We investigated
the effects of KRGCD and KRG on basal gastric blood
flow in mice. KRGCD (100 and 300 mg/kg, i.g.) signifi-
cantly increased the gastric mucosal blood flow in a
time-dependent manner; the effects reached a peak at
Figure 2 Protective effect of KRGCD on gastric mucosal lesions induced by indomethacin in mice. Stomachs from mice with vehicle (a)
and pretreated with KRGCD at doses of 30 mg/kg (b), 100 mg/kg (c), and 300 mg/kg (d) at 1 hr before indomethacin administration.
Quantitative analysis of KRGCD on the ulcer area (mm2) induced by indomethacin (e). n = 6 for each group. Each value represents the mean ±
SEM. ** p < 0.01 vs. control mice, Dunnett’s multiple-range test. Stomachs from mice with vehicle (f) and pretreated with KRGCD (100 mg/kg)
(g), TCD (76 mg/kg) (h), and APD (96 mg/kg) (i) at 1 hr before indomethacin administration. Quantitative analysis of KRGCD, TCD, or APD on the
ulcer area (mm2) induced by indomethacin (j). n = 8 for each group. Each value represents the mean ± SEM. * p < 0.05 vs. control mice,
Student’s t-test.
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Figure 3 Effect of KRGCD on histological evaluation in an HCl/ethanol-induced ulcer model. Sections of hematoxylin and eosin (HE)
staining (a-d). Section through gastric mucosa in the sham treated group (a). Microscopic appearance of lesions induced by HCl/ethanol in
gastric mucosa pretreated with vehicle (b). Microscopic appearance of lesions pretreated with 30 mg/kg of KRGCD (c). Microscopic appearance
of lesions pretreated with 300 mg/kg of KRGCD (d). Scale bar = 150 μm (upper micrograph) and 30 μm (lower micrograph).
Figure 4 Effect of KRGCD on histological evaluation in indomethacin-induced ulcer model. Sections of hematoxylin and eosin (HE)
staining (a-d). Section through gastric mucosa in the sham treated group (a). Microscopic appearance of lesions induced by indomethacin in
gastric mucosa pretreated with vehicle (b). Microscopic appearance of lesions pretreated with 30 mg/kg of KRGCD (c). Microscopic appearance
of lesions pretreated with 300 mg/kg of KRGCD (d). Scale bar = 150 μm (upper micrograph) and 30 μm (lower micrograph).
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30-40 min after KRGCD administration (Figure 6b).
KRG (100 mg/kg, i.g.) also increased the gastric mucosal
blood flow in a time-dependent manner (Figure 6c).
Discussion
In this study, the anti-ulcer effect of KRGCD was inves-
tigated in mice using HCl/ethanol and indomethacin-
induced ulcer models. These two models are the most
commonly employed tests in evaluations of anti-ulcer
activity. In addition, the effects of KRGCD on anti-oxi-
dant activity and gastric mucosal blood flow in mice sto-
mach tissue were evaluated.
KRGCD was found to significantly inhibit HCl/etha-
nol- and indomethacin-induced ulcers, and the
anti-ulcer capacity of KRGCD was determined to be
dose-dependent. Ethanol induces severe gastric mucosal
damage in humans and rodents [10-12] and rapidly
penetrates the gastric mucosa, causing membrane
damage, exfoliation of cells, and erosion. The subse-
quent increase in mucosal permeability together with
the release of vasoactive products from mast cells,
macrophages, and other blood cells can lead to vascular
injury, necrosis, and ulcer formation [13].
Oxidative stress is believed to initiate and aggravate
many digestive system diseases, including stomach
ulcers and gastric carcinoma. Especially, ethanol-induced
gastric damage has been suggested to be mediated by
the generation of free radicals [21]. Ethanol is metabo-
lized in the body and releases superoxide anion and
hydroperoxy free radicals. As previously reported, oral
administration of HCl/ethanol significantly increased the
lipid peroxidation compared with the sham treating
group, and KRGCD significantly reduced the production
of TBARS in a concentration-dependent manner. How-
ever, KRG did not attenuate the production of TBARS
in the mice stomach homogenate. These results suggest
that the anti-oxidative activity of KRGCD is not due to
KRG but to other components in KRGCD, such as Cin-
namomi cortex and Atractylodes lancea rhizome. Cinna-
momi cortex has been reported to contain very high
concentrations of antioxidants [22]. Toki-shakuyaku-san,
a kind of traditional Chinese medicine containing Atrac-
tylodes lancea rhizome, has also been reported to pos-
sess a potent anti-oxidative effect [23].
In this study, to consider the influence of another
vegetal drugs containing in KRGCD, we evaluated
Teprenon-containing drug (TCD) and Anchusan-pre-
scribed drug (APD) as positive controls. Among the
vegetal drugs in KRGCD, TCD contains Atactylodes lan-
cea rhizome and Cinnamon bark. APD also contains
Cinnamon bark, Oyster shell, and Corydalis tuber.
Because TCD had a similar beneficial effect to KRGCD
against ethanol and indomethacin induced gastric ulcer,
Atactylodes lancea rhizome which containing both in
KRGCD and TCD, not in APD, may contribute to the
potent gastroprotective effect of KRGCD. On the other
hand, as the other vegetal drugs, such as Cinnamon
bark [24] and Oyster shell [25], are reported to have a
protective effect against gastric ulcer or gastric mucosal
injury, these components may contribute to the effect of
KRGCD. However, considering the high KRG contents
Figure 5 Effect of KRGCD on lipid peroxidation . Effects of
KRGCD (a) and KRG (b) on TBARS content in in vitro mouse
stomach homogenates. n = 4 for each group. Each value represents
the mean ± SEM. * p < 0.05, ** p < 0.01 vs. control, Dunnett’s
multiple-range test. ## p < 0.01 vs. control, Student’s t-test. Effect of
KRGCD (c) on TBARS content in mice on HCl/ethanol-induced
gastric damage. Sham (n = 3), control (n = 10), 30 mg/kg of KRGCD
(n = 6), 100 mg/kg of KRGCD (n = 8), and 300 mg/kg of KRGCD
(n = 8). * p < 0.05, vs. sham treated group, Student’s t-test.
# p < 0.05, ## p < 0.01 vs. control, Dunnett’s multiple-range test.
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in KRGCD as original natural medicine, KRG may play
a prominent role in gastroprotective effects of KRGCD.
Another important finding in our study is that
KRGCD and KRG administration enhances basal gas-
tric mucosal blood flow in intact mice. A previous
study has also shown that KRG improves the systemic
blood flow, such as liver, spleen, kidney, and gastric
mucosa in rats, using the hydrogen gas clearance
method [26]. In the current study, we confirmed the
effect in mice. A laser Doppler flowmeter with a non-
contact probe allowed us to measure the gastric muco-
sal blood flow stably in mice. In figure 3b, KRGCD at
300 mg/kg increased the gastric mucosal blood flow to
around 15 (ml/min/100 g). In figure 3c, KRG at 30
mg/kg, which is in relation to 300 mg/kg of KRGCD,
also increased the flow to around 13.5 (ml/min/100 g).
Although almost similar rate of increase was obtained
between two groups, the effect of KRGCD on gastric
mucosal blood flow was slightly higher than that of
KRG. These results indicate that the other vegetal
drugs containing in KRGCD, such as Cinnamon bark
[24], may in part contribute to the effect of KRGCD
on the gastric mucosal blood flow. Sufficient gastric
mucosal blood flow is important for maintaining nor-
mal secretion, digestion, and motility of stomach and
plays an important role in the development of ulcers
[27]. To protect the gastric mucosa, a complex defense
system, which includes the production of surface
mucus and bicarbonate and the regulation of gastric
mucosal blood flow, has evolved. The main factors,
which regulate gastric blood flow, are prostaglandins,
sensory peptides released from endings of afferent
nerves, and nitric oxide (NO) [28,29]. In a previous
study, saponin fraction of KRG increased the cerebral
blood flow [30] and increased the level of nitric oxide
in the endothelial cells [31]. It has been also shown
that ginseng saponin relaxed the basilar artery in a
dose-dependent and partly endothelium-dependent
manner [32]. Therefore, our results suggest that KRG
increased the gastric mucosal blood flow, perhaps due
to the vasorelaxing action of KRG in the gastric muco-
sal vessel in the resting state. On the other hand, the
drug has a possibility to induce astriction and diarrhea
as a side effect (information from company).
Conclusions
KRGCD showed protective effects on HCl/ethanol- and
indomethacin-induced gastric mucosal injury in a dose-
dependent manner. These results lead us to believe that
KRG and its prescription may be a powerful remedy for
gastric mucosal lesions, inhibiting lipid peroxidation and
enhancing gastric mucosal blood flow.
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Figure 6 Effects of KRGCD and KRG on the gastric mucosal
blood flow. Gastric mucosal blood flow was measured using a laser
Doppler flowmeter (a). Effects of KRGCD (b) and KRG (c) on basal
gastric mucosal blood flow. n = 3-4 for each group. Each value
represents the mean ± SEM. * p < 0.05, ** p < 0.01 vs. control,
Dunnett’s multiple-range test.
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